Latest News
Latest Financial Results

Q3 2023
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2022
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.

Company Overview
ProMIS™ Neurosciences, Inc., headquartered in Toronto Ontario, and with offices in Cambridge Massachusetts, is publicly traded on the Toronto Stock Exchange (ticker symbol: PMN.TO) and Nasdaq (ticker symbol: PMN). ProMIS is a development stage biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the development and progression of neurodegenerative diseases, in particular Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD).
Toronto, Canada Office
Address
1920 Yonge Street
Suite 200
Toronto, ON M4S 3E2
Canada
Cambridge, MA U.S. Office
Address
Cambridge Innovation Center
1 Broadway
Cambridge, MA 02142
U.S.A.